Clinical Trial Update: Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

A Phase 2 pharmacodynamic and pharmacokinetic dose-ranging study evaluated inhaled tiotropium bromide solution in patients with mild to moderate COPD; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• tiotropium bromide (tiotropium)

Snippet

Sponsor: Glenmark Specialty S.A. | Conditions: Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED | Results posted: 2019-08-01